Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase‐4 inhibitors in treatment‐naïve patients with type 2 diabetes in Japan
Abstract Japan's guidelines emphasize tailored therapy, but do not guide physicians on the use of a specific regimen in drug‐naive patients. The role of long‐term initial therapy could be important in key elements of diabetes treatment, such as continuation of the initially prescribed drug. We...
Main Authors: | Takeshi Horii, Makiko Iwasawa, Jyunichi Shimizu, Koichiro Atsuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13088 |
Similar Items
-
Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study
by: Takeshi Horii, et al.
Published: (2019-07-01) -
α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches
by: Alexandra Quek, et al.
Published: (2021-01-01) -
Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo
by: Fenfen Yan, et al.
Published: (2020-01-01) -
Pengaruh Sistem Pemeliharaan secara Intensif dan Semi Intensif pada Itik Magelang
by: A. Rahayu, et al.
Published: (2020-12-01) -
Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
by: Christina S. Kwon, et al.
Published: (2018-02-01)